Context Therapeutics (CNTX) P/E (2021 - 2026)
Context Therapeutics (CNTX) P/E from Dec 31, 2021 to Jul 21, 2026. The TTM Context Therapeutics (CNTX) P/E is -1.80. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Context Therapeutics (CNTX)
| Year | P/E | Change |
|---|---|---|
| 2026 | -1.80 | -64.16% |
| 2025 | -5.03 | +62.12% |
| 2024 | -3.10 | -40.50% |
| 2023 | -5.22 | +20.08% |
| 2022 | -4.34 | -94.73% |
| 2021 | -82.45 | N/A |
Comparison Context Therapeutics (CNTX) P/E with competitors
Context Therapeutics (CNTX) P/E is -1.80.